Bayer today announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for expanded capabilities of ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global contrast injectors market since 2015 and the market is poised to grow by USD 613.47 million during 2020-2024, progressing at a CAGR of ...
GE Healthcare will offer its own brand CT Motion injector, an innovative, multi-dose, syringeless technology developed and manufactured by ulrich medical, to a growing injector market in the U.S. New ...
Bayer Pharma, a subgroup of Bayer AG, focuses on the radiology business and operates in over 100 countries worldwide. The company offers digital solutions, injection systems, and contrast agents, ...
Factors such as the growing prevalence of cancer and CVD; a large number of approvals for contrast agents; and increasing investments, funds, and grants by government organizations are driving the ...
The global market for contrast media injectors is poised for significant growth, projected to reach $2.1 billion by 2033 at a CAGR of 7.8% between 2025 and 2033. This expansion is fueled by ongoing ...
Recent research, led by Dushyant Sahani MD, Professor and Chair of Radiology at the University of Washington and presented at the 2022 Radiological Society of North America (RSNA) Congress, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results